The brain disease research of NeuroResearch Clinics is covered in depth in a new medical text book released in early 2009 (Ingrid Kohlstadt, MD of Johns Hopkins editor) and in a series of University of Minnesota Medical School papers started in 2007.

On this web page is a listing of brain disease associated with the master neurotransmitters serotonin, dopamine, norepinephrine, and epinephrine. A single disease relating to master neurotransmitters usually does not exist. Neurotransmitter brain disease in over 90% of cases is manifest as multiple diseases active simultaneously. When a neurotransmitter brain disease listed below is diagnosed the patient typically has 3 or more neurotransmitter diseases active simultaneously.

University of Minnesota Medical School neurotransmitter testing paper.

The medical text book chapter on depression written by Marty L. Hinz, MD-Ingrid Kohlstadt, MD editor-Johns Hopkins released February, 7, 2009

BRAIN DISEASE

The pages of this web site article contain an in depth discussion of a new and highly effective neurotransmitter approach to treating medical patients in clinics without drugs and drug side effects. While on the surface this approach may sound like treatment attempted by others, it is differentiated from other approaches by the high degree of effectiveness achieved and the unique way the individual components are used. This approach was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics no-drug approach in treatment, we can help.

Each brain disease listed below is treatable with the neurotransmitter optimization approach developed by NeuroResearch Clinics. For more information on individual diseases see the hyperlinks on the left column of this web page.

Serotonin, dopamine, and norepinephrine neurotransmitter levels that are not high enough cause the following brain disease

OBESITY

leads to diseases listed in the left two columns

Type II Diabetes

Other Diseases

-Decreased Life Expectancy

-Diabetes

-Heart Disease

-Increase in Stroke

-Sleep Apnea

-Knee Problems

-Back Problems

-Increased Rehabilitation Time

-Increased Rate of Injuries

-Increase in Gall Stones

-Female Fertility Problems

-Gynecologic Irregularities

-Gouty Arthritis

-Increased Lung Infections

-High Blood Pressure
-High Cholesterol

-Increase in Gastric Ulcers

-Chronic Pain

-Hiatal Hernia

-Fibromyalgia

-Myoclonus

INCREASE CANCER RISK

-Increased Colon Cancer

-Increased Uterian Cancer

-Increased Breast Cancer

AMA continuing medical education

for physicians

-Decreased Life Expectancy

-Increased Infections

-Diabetic Neuropathy

-Kidney Failure

-Macular Degeneration (blind)

-Heart Disease

-Foot Ulcers

-Vascular Disease

-Therapeutic Amputations

-Disability

-Increase in Stroke

-Impotence

High blood pressure

and

High cholesterol

-Decreased Life Expectancy

-Heart Disease

-Stroke

-Kidney Failure

-Vascular Disease

-Ischemia

Most people have more than one brain disease active simultaneously.

The incidence of brain disease increases after exposure to drugs that deplete serotonin, dopamine or norepinephrine neurotransmitter levels or exposure to neurotoxins which cause brain damage.

-Parkinson's Disease

-Obesity

-Bulimia

-Anorexia

-Depression

-Anxiety

-Panic Attacks

-Migraine Headaches

-Tension Headaches

-Premenstrual Syndrome (PMS)

-Menopausal Symptoms

-Obsessive Compulsive Disorder (OCD)

-Trichotillomania

-compulsivity

-Insomnia

-Impulsivity

-Obessionality

-Inappropriate Aggression

-Inappropriate Anger

-oppositional defiant disorder disorder in children

-Psychotic Illness

-Fibromyalgia

-Chronic fatigue syndrome

-Adrenal fatigue/burnout

-Hyperactivity

-Attention Deficit (ADD ADHD)

-Hormone dysfunction

-Adrenal dysfunction

-Dementia

-Alzheimer's disease

-Traumatic Brain Injury

-Brain fog

-Phobias

-Chronic Pain

-Nocturnal Myoclonus

-Irritable Bowel Syndrome

-Crohn’s Disease

-Ulcerative Colitis

-Cognitive Deterioration

-Functional Deterioration

-Increased mortality rate

-Organ System Dysfunction

-Chronic Stress

-Cortisol Dysfunction

-Hormone Dysfunction

-Restless Leg Syndrome

Brain Disease

research

It is no secret NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine with neurotransmitter testing as indicated to treat Attention Deficit (ADD ADHD) patients in order to achieve the results that are documented by our doctors, Proper use of these simple nutrients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. Due to their unique chemical properties nutrients have tremendous potential. The potential is only fully realized in the hands of the fully trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical approach doctors are trained in to manage the disease properly and make sure that that the treatment plan is on track to get symptoms under control.

The NeuroResearch Clinics Peer Reviewed research

The research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "The Journal of NeuroPsychiatry" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression.

University of Minnesota Medical School neurotransmitter testing paper on the research of NeuroResearch Clinics.

The medical text book chapter on depression written by Marty L. Hinz, MD-Ingrid Kohlstadt, MD editor-Johns Hopkins released February, 7, 2009

Brain Disease-research

If you need a medical speaker for AMA Category I CME call NeuroResearch Clinics, Inc.

NeuroResearch Clinics, Inc. only deals with and provides information to licensed health care professionals.

brain disease

keyz keyb

brain disease